Published by Plenum Press, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Good. 440 pp., hardcover, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Published by Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Research Ink, Takoma Park, MD, U.S.A.
Hardback. Condition: Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book.
Published by Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Tiber Books, Cockeysville, MD, U.S.A.
Hardcover. Condition: Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA.
Published by Springer / Plenum, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: The Warm Springs Book Company, Fremont, CA, U.S.A.
First Edition
Hardcover. Condition: Fine. 1st Edition. A fine copy issued without a DJ. Former owner's name on inside of front cover; slight trace of wear to pictorial boards; 1st edition with complete number line; illustrated; 8vo., 440 pages.
Published by Springer Nature B.V., 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by Springer Nature B.V., 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by Springer, 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In.
Published by Springer, 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: new.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer US, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: booksXpress, Bayonne, NJ, U.S.A.
Soft Cover. Condition: new.
Published by Springer US Okt 2012, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. 280 pp. Englisch.
Published by Springer US Mrz 1999, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both. 282 pp. Englisch.
Published by Springer US, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Scientists and clinicians attending the last New Directions in Antiviral Therapy conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretroviral.
Published by Springer US, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Scientists and clinicians attending the last New Directions in Antiviral Therapy conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretroviral.
Published by Springer, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: new.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Published by Springer US, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Published by Springer, 2013
ISBN 10: 1475792115 ISBN 13: 9781475792119
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer US, 2013
ISBN 10: 1475792115 ISBN 13: 9781475792119
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: As New. Unread book in perfect condition.